In a preclinical study, dose-dependent administration of a TRPV1 agonist, capsaicin, prevented adipogenesis in stimulated 3T3-L1-preadipocytes, and oral administration of capsaicin prevented obesity in males36. The gene discussed is TRPV1; the disease is obesity due to melanocortin 4 receptor deficiency.